Ftse Mib
38.504,19
2,04%
DAX
23.081,03
3,37%
S&P 500
5.845,03
1,16%
NASDAQ
18.545,53
1,42%
Bitcoin
89.601,36
2,72%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Ocular Therapeutix Inc (OCUL) Ocular Therapeutix Inc (OCUL) Notizie

Ocular Therapeutix Inc

OCUL
7,10
0,60 (9,23%)
Ultimo aggiornamento: 20:25:44
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
03/3/202513:19EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
03/3/202513:07EDGAR2Form 8-K - Current report
03/3/202513:00GLOBEOcular Therapeutix™ Reports Fourth Quarter and Full Year..
27/2/202500:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202500:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202500:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/2/202513:00GLOBEOcular Therapeutix™ to Present at Two Investor Conferences..
24/2/202522:54EDGAR2Form 144 - Report of proposed sale of securities
24/2/202522:33EDGAR2Form 144 - Report of proposed sale of securities
24/2/202522:32EDGAR2Form 144 - Report of proposed sale of securities
24/2/202522:30EDGAR2Form 144 - Report of proposed sale of securities
24/2/202513:00GLOBEOcular Therapeutix™ to Report Fourth Quarter and Full Year..
14/2/202513:32EDGAR2Form 8-K - Current report
14/2/202512:46EDGAR2Form SCHEDULE 13G/A - Statement of Beneficial Ownership by..
14/2/202502:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202502:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202502:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202502:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/2/202501:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/2/202522:24EDGAR2Form 144 - Report of proposed sale of securities
03/2/202513:00GLOBEOcular Therapeutix™ Announces Upcoming Presentations at the..
31/1/202522:24EDGAR2Form 144 - Report of proposed sale of securities
17/1/202513:00GLOBEOcular Therapeutix™ Reports Inducement Grant Under Nasdaq..
14/1/202513:00GLOBEOcular Therapeutix™ Shares SOL-R Enrollment Progress and..
08/1/202513:00GLOBEOcular Therapeutix™ to Provide Corporate Update During 43rd..
13/12/202413:00GLOBEOcular Therapeutix™ Reports Inducement Grant Under Nasdaq..
10/12/202413:30GLOBEOcular Therapeutix™ to Present at the 43rd Annual J.P...
02/12/202413:30GLOBEOcular Therapeutix™ Announces More Than 300 Subjects..
27/11/202413:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/11/202413:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/11/202413:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/11/202413:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/11/202413:30GLOBEOcular Therapeutix™ to Participate in December Investor and..
26/11/202400:42EDGAR2Form 144 - Report of proposed sale of securities
26/11/202400:23EDGAR2Form 144 - Report of proposed sale of securities
26/11/202400:19EDGAR2Form 144 - Report of proposed sale of securities
25/11/202423:10EDGAR2Form 144 - Report of proposed sale of securities
14/11/202423:49EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
14/11/202415:37EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
14/11/202413:30EDGAR2Form S-8 - Securities to be offered to employees in employee..
14/11/202413:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/11/202413:10EDGAR2Form 8-K - Current report
14/11/202413:00GLOBEOcular Therapeutix™ Reports Third Quarter 2024 Results and..
13/11/202413:30GLOBEOcular Therapeutix™ to Present at the Jefferies London..
12/11/202413:30GLOBEOcular Therapeutix™ Appoints Namrata Saroj, OD, as Chief..
08/11/202420:17EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
06/11/202413:30GLOBEOcular Therapeutix™ to Report Third Quarter 2024 Results on..
16/10/202422:25EDGAR2Form 144 - Report of proposed sale of securities
15/10/202413:30GLOBEOcular Therapeutix™ Announces Accelerated Timelines for..
09/10/202423:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 6,53 Min: 6,51 Max: 7,21
Chiusura: 6,50

La tua Cronologia

NASDAQ
OCUL
Ocular Therapeutix
BIT
F21326
Vontobel Financial Produ...
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci